Method and device for administering dexmedetomidine transdermally
Patent 5217718 Issued on June 8, 1993. Estimated Expiration Date: 
September 17, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
September 17, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3598122 3598123 3926188 Method and device for administering dexmedetomidine transdermally Patent #: 5124157 InventorsAssigneeApplicationNo. 761408 filed on 09/17/1991US Classes:424/449, Transdermal or percutaneous424/448Pressure sensitive adhesive meansExaminersPrimary: Page, Thurman K.Attorney, Agent or FirmInternational ClassA61F 013/00AbstractTransdermal administration of dexmedetomidine, the dextrorotatory isomer of medetomidine, is described. The method involves sedating a patient by administering dexmedetomidine to a predetermined area of skin at an administration rate and for a time period effective to achieve the desired level of sedation. A therapeutic system for transdermally administering the drug is also provided. The therapeutic system is in the form of a skin patch which is a laminated composite of a backing layer, an optional anchor adhesive layer, a contact adhesive layer, and one or more additional layers. | |
